作为治疗多发性骨髓瘤的核心药物，来那度胺、泊马度胺作为治疗多发性骨髓瘤的明星药物，同时也是前沿 PROTAC 创新药的核心配体，市场需求持续攀升。但传统釜式合成不仅要耗费40小时以上，步骤繁琐、安全风险高，产能始终难以突破。 近期，陈芬儿团队 ...

Please provide your email address to receive an email when new articles are posted on . In patients with uveitis, the 5-year incidence of immune-mediated inflammatory disease was 8.52%. The findings ...

Eli Lilly hits a 52-week high on retatrutide, Mounjaro & Kisunla growth, but valuation and Omvoh demand prompt a Hold rating.

对多发性骨髓瘤（MM）发病机制所依赖分子机制的全面理解，对于开发能够克服疾病异质性和治疗后复发的治疗策略至关重要。本综述聚焦于转录因子（TFs），其作为基因表达的关键调控因子，在正常造血过程和多发性骨髓瘤生物学中发挥核心作用。首先，研究人员讨论了转录因子在线淋 对多发性骨髓瘤（MM）发病机制所依赖分子机制的全面理解，对于开发能够克服疾病异质性和治疗后复发的治疗策略至关重要。本综述聚焦于转录因子（T ...

FDA approves Keytruda combo for kidney cancer as sales rise. Click here for this MRK update.

3 MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK 4 Centre for Genomics and Experimental Medicine, Institute of Genetics and ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Nice to meet you. I run the "Anticancer Drug Encyclopedia." I am a practicing pharmacist with certifications and expertise in the oncology field. While working in cancer treatment as a pharmacist, ...

You are free to share (copy and redistribute) this article in any medium or format within the parameters below: Creative Commons (CC): This is a Creative Commons ...